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Post-translational modifications of histones, such as
acetylation and methylation, are differentially positioned
in chromatin with respect to gene organization. For ex-
ample, although histone H3 is often trimethylated on ly-
sine 4 (H3K4me3) and acetylated on lysine 14 (H3K14ac) at
active promoter regions, histone H3 lysine 36 trimethyla-
tion (H3K36me3) occurs throughout the open reading
frames of transcriptionally active genes. The conserved
yeast histone acetyltransferase complex, NuA3, specifi-
cally binds H3K4me3 through a plant homeodomain (PHD)
finger in the Yng1 subunit, and subsequently catalyzes the
acetylation of H3K14 through the histone acetyltrans-
ferase domain of Sas3, leading to transcription initiation at
a subset of genes. We previously found that Ylr455w (Pdp3),
an uncharacterized proline-tryptophan-tryptophan-proline
(PWWP) domain-containing protein, copurifies with stable
members of NuA3. Here, we employ mass-spectrometric
analysis of affinity purified Pdp3, biophysical binding as-
says, and genetic analyses to classify NuA3 into two func-
tionally distinct forms: NuA3a and NuA3b. Although NuA3a
uses the PHD finger of Yng1 to interact with H3K4me3 at
the 5-end of open reading frames, NuA3b contains the
unique member, Pdp3, which regulates an interaction be-
tween NuA3b and H3K36me3 at the transcribed regions of
genes through its PWWP domain. We find that deletion of
PDP3 decreases NuA3-directed transcription and results in
growth defects when combined with transcription elonga-
tion mutants, suggesting NuA3b acts as a positive elonga-
tion factor. Finally, we determine that NuA3a, but not
NuA3b, is synthetically lethal in combination with a deletion
of the histone acetyltransferase GCN5, indicating NuA3b
has a specialized role at coding regions that is independent
of Gcn5 activity. Collectively, these studies define a
new form of the NuA3 complex that associates with
H3K36me3 to effect transcriptional elongation. MS data
are available via ProteomeXchange with identifier
PXD001156. Molecular & Cellular Proteomics 13:
10.1074/mcp.M114.038224, 2883–2895, 2014.
Eukaryotic DNA is wrapped around octamers of the evolu-
tionarily conserved core histone proteins H3, H4, H2A, and
H2B, forming nucleosomes—the fundamental unit of chroma-
tin. Chromatin acts as a barrier to the transcriptional machin-
ery, and therefore precise coordination of nucleosome orga-
nization is required for the passage of RNA polymerase II
(RNAPII)1 (1–3). Nucleosome organization is regulated by
chromatin remodelers, histone chaperones, and other com-
plexes that enzymatically add, remove, or bind (“write,”
“erase,” or “read,” respectively) post-translational modifica-
tions (PTMs) on histones (4–7). Together, these factors ensure
that genes remain accessible to transcription factors, activa-
tors or coactivators, and RNAPII (5). Critically, these factors
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also function to restore chromatin structure following the pas-
sage of RNAPII during transcription elongation (3, 8).
Histone PTMs are established at gene loci in a context spe-
cific manner, typically defined by the position along a gene (i.e.
promoters versus open reading frames (ORFs)), as well as the
transcriptional status of that gene (4, 6, 9–14). The dual capacity
of chromatin complexes to “read” and “write” histone PTMs
confines certain PTM combinations to discrete regions within
genomic loci (15–20). For example, histone H3 is often combi-
natorially modified by trimethylation on lysine 4 (H3K4me3) and
acetylation, particularly on lysine 14 (H3K14ac), at the 5-ends
of actively transcribed genes (12, 13). NuA3, a conserved S.
cerevisiae histone acetyltransferase (HAT) complex (21), specif-
ically binds H3K4me3 that is generated by the Set1 histone
methyltransferase (HMT), through the plant homeodomain
(PHD) finger in the Yng1 subunit (an ortholog of human ING5)
(19, 22–27). NuA3 then acetylates H3K14 on the same H3
molecule through the HAT domain of Sas3 (an ortholog of
human MYST3) (19, 23–25). Subsequently, additional factors
bind either NuA3-catalyzed acetylation or NuA3 subunits them-
selves, including the remodel the structure of chromatin (RSC)
chromatin-remodeling complex (that contains an H3K14ac-
binding bromodomain) and the facilitates chromatin transcrip-
tion (FACT) histone chaperone complex (that binds to Sas3), to
promote transcription initiation at a subset of genes (19, 25,
28–31).
Other histone PTMs positioned within gene bodies further
facilitate transcription and maintain transcript fidelity (3, 8, 10,
32). In Saccharomyces cerevisiae, the Set2 HMT localizes to the
bodies of actively transcribed genes (13, 33) by physically bind-
ing to the hyperphosphorylated C-terminal domain (CTD) of
RNAPII (34–39). CTD binding by Set2 is required for the estab-
lishment of H3K36me3 (34). H3K36 methylation correlates with
transcription elongation (13, 34, 35, 37, 40), and maintains chro-
matin integrity by recruiting complexes that collectively restore
chromatin structure (3, 8, 32). For example, the histone deacety-
lase (HDAC) complex, Rpd3S, engages H3K36me2 via the
chromodomain of Eaf3 and the PHD finger of Rco1 (18, 41–47).
Rpd3S generates a hypoacetylated environment behind the
elongating RNAPII, which compacts chromatin and re-
presses intergenic or “cryptic” transcription (41, 44, 45, 48,
49). H3K36me3 also maintains chromatin integrity by block-
ing trans-histone exchange through at least two mechanisms:
the steric reduction of histone chaperone affinity for histone
targets (50) and the recruitment of chromatin remodelers that
preserve H3K36me3/hypoacetylated histones (3, 51, 52).
Specifically, H3K36me3 precludes Asf1 from depositing
newly synthesized histones (50) and recruits the Isw1b ATP-
dependent remodeler, via the proline-tryptophan-tryptophan-
proline (PWWP) domain of the Ioc4 subunit, to position
nucleosomes in a manner that stimulates Rpd3S activity (51–
53). Recently, human PWWP domain proteins have been
shown to bind H3K36me3 (20, 54) and perform a variety of
functions, including the regulation of transcription (55, 56),
DNA methylation guidance (57), and alternative splicing (58).
Using recent advances in mass spectrometry, we previ-
ously found that Ylr455w, an uncharacterized PWWP domain-
containing protein (59–61), copurifies with stable members of
the NuA3 HAT complex (19). We propose that Ylr455w be
called Pdp3: PWWP domain protein in NuA3. Moreover, Pdp3
(Q09842) is also the name of a PWWP domain-containing
protein in Schizosaccharomyces pombe that interacts with
homologous subunits of the NuA3 complex (62).
Here, we find evidence that two functionally distinct forms
of NuA3 exist. One form of NuA3 binds H3K4me3, through the
PHD finger of Yng1, and acetylates H3K14 at the 5-ends of
actively transcribed genes to promote transcription initiation
(19, 24, 26, 27). In contrast, an interaction between Pdp3 and
NuA3 recruits the complex to chromatin, through the Pdp3
PWWP domain binding to H3K36me3. Deletion of the PDP3
gene decreases NuA3-directed transcription and results in
growth defects when combined with transcription elongation
mutants, suggesting Pdp3-associated NuA3 functions in the
transcription elongation process. Although H3K36me2/3 can
act as a repressive mark that protects chromatin integrity
during transcription elongation (3, 8, 32), the work described
in this study suggests that H3K36me3 can also act to posi-
tively regulate transcription elongation through the recruit-
ment of the NuA3 complex via Pdp3.
EXPERIMENTAL PROCEDURES
S. cerevisiae Strains—All strains are described in supplemental
Table S1.
Escherichia coli and S. cerevisiae Plasmids—All constructs are
described in supplemental Table S2.
Peptide Sequences—All peptide sequences are listed in supple-
mental Table S3.
Primer Sequences—Primers were designed by Primer3 to target
the 5-end of our genes of interest. All primer sequences are listed in
supplemental Table S4.
Mass Spectrometric Protein Identification—Pdp3-TAP protein
complex purification was performed with S. cerevisiae grown to log
phase in yeast extract peptone dextrose (YPD), essentially as de-
scribed, to maintain complex integrity (61, 63). Proteins copurifying
with Pdp3 were subjected to tandem MS analysis of peptides with a
Thermo LTQ-XL mass spectrometer coupled to an Eksigent nanoLC
2D system as previously described (30). Spectral counts and proteins
were identified with Mascot (Matrix Science, London, UK; version
2.3.01).
Database Searching—Tandem mass spectra were extracted by
Thermo ExtractMSn version 1.0.0.8. Charge state deconvolution and
deisotoping were not performed. All MS/MS samples were analyzed
using Mascot (Matrix Science, London, UK; version 2.3.01). Mascot
was set up to search the SwissProt_57.15 database (selected for S.
cerevisiae, 57.15, 6973 entries), assuming the digestion enzyme was
nonspecific. Mascot was searched with a fragment ion mass toler-
ance of 0.60 Da and a parent ion tolerance of 2.0 Da. The iodoacet-
amide derivative of cysteine was specified in Mascot as a fixed
modification. S-carbamoylmethylcysteine cyclization at the N-termi-
nus, oxidation of methionine, pyro-carbamidomethyl formation at the
N-terminus, acetylation of asparagine, and the presence of proline at
the N-terminus were specified in Mascot as variable modifications.
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Criteria for Protein Identification—Scaffold (version Scaffold_4.0.1,
Proteome Software Inc., Portland, OR) was used to validate MS/MS-
based peptide and protein identifications. Peptide identifications
were accepted if they could be established at greater than 20.0%
probability by the Peptide Prophet algorithm (64). Protein identifica-
tions were accepted if they could be established at greater than
95.0% probability and contained at least one identified peptide. Pro-
tein probabilities were assigned by the Protein Prophet algorithm (65).
Proteins that contained similar peptides, and could not be differenti-
ated based on MS/MS analysis alone, were grouped to satisfy the
principles of parsimony. The mass spectrometry proteomics data
have been deposited to the ProteomeXchange Consortium (http://
proteomecentral.proteomexchange.org) via the PRIDE partner repos-
itory (66) with the data set identifier PXD001156 (67–69).
Protein Expression—PDP3 constructs were made with an N-termi-
nal HIS6-pfuMBP(60–434)-FLAG tag (pET28a derivative vector ob-
tained from the G. Bowman Laboratory, Johns Hopkins University)
and/or an N-terminal Thioredoxin-HIS6-S●tag tag (pET32a vector,
Millipore). Proteins were exogenously expressed in chemically com-
petent BL21 E. coli (Invitrogen, Carlsbad, CA) after overnight induc-
tion with 1 mM IPTG at 18–20 °C in LB medium. Point mutants were
made with the QuikChange Site-Directed Mutagenesis Kit (Strat-
agene, LaJolla, CA) and expressed as described.
Protein Purification—For pull-down assays, BL21 cells (pET28a
constructs) were resuspended in purification buffer (50 mM Tris pH
7.5, 500 mM NaCl, 40 mM imidazole, 10% glycerol, 2 mM -ME, 1 mM
phenylmethanesulfonyl fluoride (PMSF), and 2 mM benzamidine, pH
8.0) and lysed by sonication (Branson). Clarified lysate was nutated
with Ni-NTA agarose resin (Invitrogen) for at least 1 h at 4 °C. Resin
was washed with purification buffer and protein was eluted with
purification buffer containing 300 mM imidazole. Protein was flash
frozen in liquid nitrogen and stored at 80 °C. For fluorescence
polarization assays, BL21 cells (pET32a constructs) were resus-
pended in purification buffer (50 mM Tris pH 7.7, 500 mM NaCl, 10%
glycerol, 5 mM dithiothreitol (DTT), 1 mM PMSF, and 2 mM benzami-
dine) and lysed with a microfluidizer (Watts Fluidair). Clarified lysate
was run through a BioScale Mini Profinity IMAC cartridge (BioRad,
Hercules, CA) using an AKTA Purifier system (GE Healthcare). The
cartridge was washed with purification buffer containing 12 mM im-
idazole and protein was eluted with purification buffer containing 125
mM imidazole. Protein was exchanged into gel filtration buffer (50 mM
Tris pH 7.5, 500 mM NaCl, 10% glycerol, and 5 mM DTT) and sepa-
rated by a Superdex 200 26/60 column (GE Healthcare) using an
AKTA Purifier system (GE Healthcare). Monomeric protein was flash
frozen in liquid nitrogen and stored at 80 °C.
Cellular Pull-down Assays—TAP-tagged S. cerevisiae strains were
grown to mid-log phase in YPD, cryogenically lysed with a mixer mill
(Retsch MM301), and stored at 80 °C. Cells (1 g per pull-down
condition) were homogenized (ProScientific) in 650 mM extraction
buffer (650 mM NaCl, 20 mM HEPES pH 7.9, 25% glycerol, 1.5 mM
MgCl2, 0.2 mM EDTA, 1 mM PMSF, 0.2% Triton X-100, 1% bovine
serum albumin (BSA), and 40 mM imidazole) at a ratio of 1 ml buffer
per 1 g yeast and nutated for 1 h at 4 °C. Clarified extracts were
diluted to 300 mM NaCl with “no-salt” extraction buffer, mixed with
Ni-NTA agarose resin (Invitrogen) (100 l per sample precoated with
Pdp3 protein), and nutated for 30 min at 4 °C. Resin was washed five
times with 300 mM wash buffer (300 mM KCl, 20 mM HEPES pH 7.9,
0.2% Triton X-100, 1% BSA, and 40 mM imidazole) and one time with
buffer containing 10 mM NaCl and 4 mM HEPES pH 7.9. Resin was
incubated in 2X SDS-PAGE loading buffer containing 300 mM imid-
azole for 10 min to elute Pdp3-bound proteins. Samples were boiled
for 5 min, resolved on 8% SDS-polyacrylamide gels, transferred to
polyvinylidene fluoride (PVDF) membrane, and probed with antibodies
recognizing the PrA (DAKO: P0450, 1/1,500) and FLAG (SIGMA:
F3165, 1/1,000) tags. Immunoblots were visualized using HRP-con-
jugated secondary antibodies and ECL solution (GE Healthcare). In-
puts represent 0.02–0.05% of total yeast lysate.
Peptide Synthesis for Pull-down Assays—Peptides were synthe-
sized as previously described by the C. D. Allis Laboratory (The
Rockefeller University) or the UNC Peptide Synthesis and Arraying
Core Facility (70).
Peptide Pull-down Assays—Steptavidin-coupled Dynabeads (Invit-
rogen) (25 l per sample) were incubated with biotinylated histone
peptides (1 g per sample) in binding buffer (20 mM HEPES pH 7.9,
150 mM NaCl, 0.5 mM PMSF, 20% glycerol, 0.2% Triton X-100, and
1% BSA) for 1 h at room temperature. Unbound peptide was washed
in binding buffer and beads were incubated with purified Pdp3 pro-
teins (20 g per sample) for 1 h at room temperature. Beads were
washed three times for 5 min each with binding buffer, and one time
with buffer containing 4 mM HEPES pH 7.9, 10 mM NaCl, 0.5 mM
PMSF, 20% glycerol, and 0.2% Triton X-100. Peptide-bound proteins
were eluted in boiling 2X SDS-PAGE loading buffer. Samples were
resolved on 15% SDS-polyacrylamide gels, transferred to PVDF
membrane, and probed with antibodies recognizing the FLAG
(SIGMA: F3165, 1/1,000) and streptavidin (Molecular Probes: S-911,
1/10,000) tags. Immunoblots were visualized using HRP-conjugated
secondary antibodies and ECL solution (GE Healthcare). Inputs rep-
resent 0.5 g of Pdp3 proteins.
Peptide Synthesis for Fluorescence Polarization Assays—Fluores-
cent peptides were synthesized using standard Fmoc-solid phase
peptide chemistry on a Prelude Peptide Synthesizer (Protein Tech-
nologies). Peptides were made on a 0.05 mmol scale with four equiv-
alents of amino acids using Rink Amide AM resin (Novabiochem) to
generate peptide amides. 5-Carboxyfluorescein (5-FAM) (Chempep)
was coupled to the peptides using Lys(ivDde) (Chempep). The ivDde
protecting group was orthogonally removed using standard deprotec-
tion procedures. The resulting peptides were typically cleaved using
TFA/thioanisole/water/triisopropylsilane/phenol (87.5:2.5:2.5:2.5:5 v/v)
and purified with a Varian Dynamax Microsorb C18 preparative column
(Agilent). Purified peptide was lyophilized and its mass was confirmed
with an Applied Biosystems Voyager DE-STR MALDI-TOF mass spec-
trometer (Invitrogen). Of note, to obtain the H3K79me3 5-FAM-linked
peptide, it was necessary to install Fmoc-(FmocHmb)Phe-OH (Nova-
biochem) at F84.
Fluorescence Polarization Assays—Binding assays were performed
as described in (71) with the following modifications. Full-length pu-
rified wild-type Pdp3, F18A, and W21A proteins were exchanged into
FP buffer (50 mM Tris pH 7.5, 150 mM NaCl, and 5 mM DTT) and
concentrated to 260–430 M using Amicon Centrifugal Filter Units
MWCO 30,000 (Millipore). Binding assays were performed in a 60 l
volume with 96 well half area black flat bottom nonbinding surface
plates (Corning). Protein was serially diluted with FP Buffer in
twofold increments and incubated with 120 nM of 5-FAM-labeled
histone peptides. Following a 30 min equilibration period, fluores-
cence was detected at room temperature with an Infinite M1000
plate reader (Tecan, Durham, NC) using a 470 nm excitation filter
and 527  20 nm emission filter. Binding curves were analyzed by
the total binding equation Y  Bmax* X/(Kd  X)  NS * X 
Background, where Bmax  1 and nonspecific (NS) and background
variables are constrained to be equal between peptides, using
Prism 5.0 (GraphPad Inc., San Diego, CA). Error bars represent the
S.D. of a representative experiment (n  2) performed in triplicate.
Yeast Strains and Cell Spotting Assays—S. cerevisiae strains were
created using heterologous gene replacement (72). Strains were
grown on YPD or synthetic complete (SC) media as indicated. BUR1
delete shuffle strains were grown on SC-Ura plates to maintain the
wild-type BUR1 plasmid prior to plating on media containing the drug
5-Fluoroorotic acid (5-FOA) (73). For cell spotting assays, either 0.5 or
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2 ODs of cells were fivefold serially diluted, spotted onto the appro-
priate plates, and incubated at 30 °C for 2–3 days as indicated.
Immunoblot Analyses for Chromatin Association Assay—5 ODs of
cells were isolated and lysed by bead beating in SUTEB buffer (1%
SDS, 8 M urea, 10 mM Tris pH 6.8, 10 mM EDTA, and 0.01% bro-
mphenol blue) for 3 min. The lysates were then boiled for 10 min and
the supernatant was clarified and isolated. 5 l of extracts were
resolved on 15% SDS-polyacrylamide gels and then transferred to
PVDF membrane for 90 min at 45 mA. Blots were dried in methanol,
washed in TBST (Tris buffered saline with 0.05% Tween 20), and then
incubated overnight at 4 °C with the indicated antibodies: Protein A
(Sigma Aldrich), G6PDH (Sigma Aldrich), H3 (in house), H4 (Abcam:
ab10158), H3K14ac (Millipore: 07–353), H3K36me3 (Abcam: ab9050),
and H3K4me3 (Active Motif: 39159). Immunoblots were visualized
using HRP-conjugated secondary antibodies and ECL Prime solution
(GE Healthcare).
Chromatin Association Assay—Strains were grown overnight in
YPD to confluence. Each strain was diluted to 0.1 ODs in 50 mLs of
YPD and grown to an OD of 0.8–1. 40–50 ODs of cells were then
isolated, washed with water and SB buffer (1 M Sorbitol, 20 mM Tris.Cl
pH 7.4), and frozen at 80 °C until ready for isolation. Cells were
resuspended in 1 ml of PSB buffer (20 mM Tris.Cl pH 7.4, 2 mM EDTA,
100 mM NaCl, and 10 mM -ME), followed by addition of 1 ml of SB
buffer. Cells were then spheroplasted with Zymolyase (Seikagaku
Biobusiness, Rockville, MD) for 30 min at room temperature. Sphero-
plasts were spun down at 2000  g and washed twice with LB (0.4 M
Sorbitol, 150 mM potassium acetate, 2 mM magnesium acetate, and
20 mM PIPES pH 6.8). TritonX-100 was added to LB (final concentra-
tion of 1%). Cells were lysed for 15 min on ice. Chromatin was
isolated by spinning down lysates at 5000  g for 15 min. The
supernatant was collected and saved as the “soluble” fraction. The
chromatin was washed once more with LB and then resuspended into
an equal volume to that of the “soluble” fraction. Volume equivalents
were resolved on 15% SDS-polyacrylamide gels and subjected to
immunoblot analysis.
Relative Transcript Levels—Total RNA was prepared from TAP-
tagged YNG1, PDP3, yng1	, and pdp3	 S. cerevisiae strains via
Trizol (Invitrogen) and digested with Turbo DNase (Invitrogen). cDNA
was synthesized with the Superscript III First Strand Synthesis Sys-
tem (Invitrogen). Differences in transcript levels of control genes and
NuA3 target genes were measured by qPCR using Power SYBR
Green PCR Master Mix (Invitrogen) and a Real Time PCR system
(Applied Biosystems, Foster City, CA, v2.1). The relative transcript
levels from mutant strains as compared with wildtype were calculated
using the relative standard curve method. Error bars represent the
S.E. of a representative experiment (n  4) done in triplicate. Statis-
tical significance was determined by an unpaired two-tailed t test.
RESULTS
Pdp3 Interacts with Members of the NuA3 HAT Complex—
Eaf6, Nto1, Sas3, Taf14, and Yng1 were previously identified
as stable members of the S. cerevisiae NuA3 HAT complex
(19, 21, 24, 25). Pdp3 (Ylr455w), an uncharacterized PWWP
domain-containing protein (59–61), also showed modest as-
sociation with the complex (19), as determined through iso-
topic differentiation of interactions as random or targeted
(i-DIRT) technology (63). Interestingly, BRPF1, a component
of human MOZ/MORF HAT complexes and homolog of yeast
Nto1, contains a PWWP domain that is absent in Nto1 (23, 55,
56). We reasoned Pdp3 might function similarly to the PWWP
domain of BRPF1 in the NuA3 complex. Genomically TAP-
tagged Pdp3 was isolated from S. cerevisiae using a method
that preserves complex integrity (61, 63). Proteins copurifying
with Pdp3-TAP were resolved by SDS-PAGE and subjected to
MS/MS analysis. Using a 95% protein confidence threshold,
96 proteins were identified by MS/MS (Fig. 1A, supplemental
Tables S5 and S6). A functional classification of the proteins
identified revealed 12 proteins with functions related to tran-
scription (Fig. 1A, supplemental Table S5). The remaining 84
proteins were “nonspecific” copurifying proteins (e.g. ribo-
somal, metabolic, nucleolar, and heat shock) typically ob-
served in these types of large-scale affinity enrichments (sup-
plemental Table S6) (30, 63, 74, 75). Specific proteins
copurifying with Pdp3-TAP include all stable members of
NuA3 (Eaf6, Nto1, Sas3, Taf14, and Yng1) (19, 21, 24, 25),
core histones (H3, H4, H2A, and H2B), and components of
RNAPII (Rpb2, Rpb4). These copurifications suggest that
Pdp3 is a component of the NuA3 complex and that Pdp3 is
involved transcriptional regulation.
To confirm that Pdp3 is a member of the NuA3 complex, we
tested the ability of full-length recombinant Pdp3 to pull down
NuA3 proteins from cellular extracts (Fig. 1B). HIS6-FLAG-
tagged Pdp3 was purified from E. coli and incubated with
lysates from S. cerevisiae endogenously expressing TAP-
tagged NuA3 subunits. Immunoprecipitated samples were
FIG. 1. Pdp3/YLR455W is associated with the NuA3 complex,
chromatin, and RNAPII. A, Proteins copurifying with Pdp3-TAP bait
that are involved in transcriptional regulation. Bulk MS/MS data are
reported for proteins affinity purified by Pdp3 after searching with
Mascot. B, Whole cell extracts (WCEs) from the indicated TAP-tagged
yeast strains were immunoprecipitated with HIS6-FLAG-Pdp3 treated
() and untreated (-) resin. WCEs (inputs) and immunoprecipitated
samples (IPs) were resolved by SDS-PAGE. The presence of NuA3
complex members was monitored by western blotting.
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resolved by SDS-PAGE and visualized with an antibody
against the TAP tag. HIS6-FLAG-Pdp3 interacts with Yng1,
Nto1, and Sas3 (Fig. 1B), supporting the MS/MS results (Fig.
1A, supplemental Table S5). Neither Taf14 nor Eaf6 were
detected in recombinant Pdp3 pull-downs, which may indi-
cate that these proteins do not interact with Pdp3 (Fig. 1B,
data not shown); however, we cannot exclude the possibility
that the TAP tag disrupts native interactions. Also, because
Taf14 is a member of multiple chromatin-associated com-
plexes (76), the quantity of soluble Taf14 available to be pulled
down in this assay may be insufficient to detect.
Pdp3 Specifically Engages H3K36me3 Through a Con-
served PWWP Domain—H3K36me3 localizes to the body of
actively transcribed genes, and is associated with transcrip-
tion elongation in yeast and humans (13, 34, 35, 37, 40).
BRPF1, a human homolog of yeast Nto1 (23), engages
H3K36me3 through a PWWP domain (supplemental Fig. S1)
(55, 56) that is absent in Nto1. Interestingly, structural mod-
eling predicts that Pdp3 contains a PWWP domain with aro-
matic residues critical for methyl-lysine binding, as well as
beta strands and alpha helices conserved in other PWWP-
domain containing proteins that bind methyl-lysine (Figs. 2A,
FIG. 2. NuA3 specifically interacts with H3K36me3 through the PWWP domain of Pdp3. A, Clustal W alignment of PWWP domain-containing
proteins. Beta sheets (arrows/underlined sequence) and alpha helices (cylinders/gray shading) are annotated. Aromatic cage residues are
highlighted in yellow. See also Supplemental Fig. S1. B, Schematic representation of the Pdp3 protein. The predicted (red outline) and functional
(tan hexagon) PWWP domains are annotated. Aromatic cage residues F18, W21, and F48 are highlighted in yellow. C, Peptide pull-down assays
were performed with full-length HIS6-FLAG-Pdp3 and biotinylated histone peptides. Purified protein (input) and immunoprecipitated samples (IPs)
were resolved by SDS-PAGE. Binding was monitored by western blotting. D, Peptide pull-down assays were performed with full-length
HIS6-FLAG-Pdp3, mutants F18A, W21A, and F48A, truncations PWWP(1–74), PWWP(1–110), PWWP(2–150), PWWP(1–219), and C-term(74–304), and
biotinylated histone peptides. Purified proteins (inputs) and immunoprecipitated samples (me0 and 36me3) were resolved by SDS-PAGE. Binding
was monitored by western blotting. E, Fluorescence polarization assays were used to measure binding affinities of full-length Stag-Pdp3 and
mutants F18A and W21A to the indicated 5-FAM-labeled histone peptides. Error bars represent the S.D. of a representative experiment (n  2)
performed in triplicate.
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2B, and supplemental Fig. S1). Because of the structural
conservation with the BRPF1 PWWP domain, and the homol-
ogy between the human and yeast HAT complexes, we rea-
soned that Pdp3 might bind H3K36me3. To test for this pos-
sibility, we interrogated the ability of full-length recombinant
Pdp3 to bind to trimethylated histone peptides (Fig. 2C).
Biotinylated peptides were immobilized on streptavidin resin
and incubated with HIS6-FLAG-Pdp3. Immunoprecipitated
samples were resolved by SDS-PAGE and visualized with
antibodies against FLAG and streptavidin. Pdp3 preferentially
engages H3K36me3 compared with all other trimethylated
lysine residues tested (Fig. 2C).
A Conserved Aromatic Cage within the Pdp3 PWWP Do-
main is Required for Binding H3K36me3—Like other Royal
Family reader modules, PWWP domains employ an aromatic
cage to interact with specific trimethylated histones (supple-
mental Fig. S1) (7, 20, 56, 77). For example, BRPF1 requires
aromatic residues Y1096, Y1099, and F1147 to coordinate the
trimethylammonium group of H3K36me3 (supplemental Fig.
S1) (56). These aromatic residues are conserved in the PWWP
domain of Pdp3 at positions F18, W21, and F48 (Figs. 2A, 2B,
and supplemental Fig. 1). To determine whether Pdp3 uses an
aromatic cage to bind H3K36me3, we tested the ability of
H3K36me3 peptide to pull down full-length recombinant Pdp3
mutated at residues F18, W21, or F48 (Fig. 2D). All three
mutations independently abolish the interaction between
Pdp3 and H3K36me3 peptide (Fig. 2D), suggesting Pdp3
requires a conserved aromatic cage to bind chromatin.
The Pdp3 PWWP Domain is Necessary and Sufficient for
Binding H3K36me3—We next wanted to determine whether
the predicted PWWP domain of Pdp3 was sufficient for
H3K36me3 binding. Uniprot defined the Pdp3 PWWP domain
as the amino acid residues spanning 7–68 (Fig. 2B) (78).
However, we found that truncated Pdp3 (PWWP1–74) is unable
to bind H3K36me3 peptide (Fig. 2D), suggesting residues
beyond the predicted PWWP domain are necessary for Pdp3
function. From the crystal structure of BRPF1 (56), we ob-
served that two C-terminal alpha-helices support the aromatic
cage and may be critical for engagement of H3K36me3 (sup-
plemental Fig. S1). These alpha-helices are conserved in the
structural model of Pdp3 (supplemental Fig. S1) (79), yet
extend beyond the predicted PWWP domain (Figs. 2A, 2B).
We created Pdp3 constructs to include increasing seg-
ments of the (modeled) C-terminal alpha-helices and tested
the ability of H3K36me3 peptide to pull down PWWP1–110,
PWWP2–150, and PWWP1–219. As shown in Fig. 2D, PWWP2–150
restores binding to H3K36me3 and thus represents the func-
tional PWWP domain of Pdp3 (Fig. 2B). These data suggest
Pdp3, and likely other PWWP domain proteins, require ex-
tended alpha-helical regions for aromatic cage stability and
function.
Biophysical Characterization of the Interaction between Pdp3
and H3K36me3—To biophysically quantitate the specificity of
the interaction between Pdp3 and H3K36me3, we performed
fluorescence polarization assays using full-length recombinant
Stag-Pdp3 and 5-FAM-labeled histone peptides (Fig. 2E, Table
I). As expected from our pull-down assays, Pdp3 favors binding
to the H3K36me3 peptide over other known targets of PWWP
domain proteins, such as H3K79me3 and H4K20me3, with a Kd
of 69.51  3.7 M (Fig. 2E, Table I) (54, 80). Notably, this value
is one of the lowest reported dissociation constants for PWWP
domain proteins that bind histones (supplemental Table S7) (54,
56, 57, 80, 81). We also generated Pdp3 mutants predicted to
disrupt the aromatic cage and hence interaction with
H3K36me3 (F18A and W21A). These mutants reduced
H3K36me3 peptide binding 10-fold compared with wild-type
Pdp3 (Fig. 2E, Table I). Pdp3 also showed weak binding to
H3K36me2 peptide with a Kd of 414 M (Fig. 2E, Table I).
Importantly, the sixfold increase in specificity of Pdp3 for
H3K36me3, over H3K36me2, suggests Pdp3 has a distinct
function from the Rpd3S HDAC complex, which preferentially
engages H3K36me2 (18, 41, 42, 45, 82).
Pdp3 Requires H3K36me3 to Bind Chromatin—To further
understand the biological role of Pdp3, we next determined
whether Pdp3 binds H3K36me3 in vivo. We deleted the
H3K36me3 methyltransferase, SET2, in the PDP3-TAP back-
ground and used a chromatin association assay to separate
soluble proteins from those that bind to chromatin. For added
controls, we also deleted the H3K4me3 methyltransferase,
SET1, and the NuA3 H3K4me3 binding protein, YNG1. Strik-
ingly, in the absence of Set2, and thus H3K36me3, we ob-
serve an almost complete ablation of Pdp3 binding to chro-
matin (Fig. 3A), indicating H3K36me3 is critical for Pdp3
localization in vivo. In contrast, Pdp3 remains bound to chro-
matin in the absence of Set1 (H3K4me3) and Yng1 (Fig. 3A).
The observation that Pdp3 engages chromatin independently
of both H3K4me3 and Yng1 suggests that Pdp3 targets NuA3
to active coding regions via an interaction with H3K36me3
(13, 14, 50). Interestingly, in the absence of Yng1, we note a
slight decrease in the amount of chromatin-bound Pdp3 (Fig.
3A), as well as lower levels of cellular Pdp3 (supplemental Fig.
S2A). Together, these data suggest Pdp3 is moderately un-
TABLE I
Dissociation constants obtained from fluorescence polarization as-
says. The total binding equation was used to calculate dissociation
constants with Graphpad Prism software. Kd values were tabulated
from two independent experiments (performed in triplicate) and aver-
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stable in yng1	 cells, perhaps because of an inability to be
incorporated into NuA3.
We next deleted SET1, SET2, and PDP3 in the YNG1-TAP
background. In contrast to Pdp3, Yng1 remains bound to
chromatin in the absence of either Set1 or Set2 (Fig. 3B).
Furthermore, Yng1 levels are not significantly altered in
pdp3	 cells (supplemental Fig. S2B). These results are con-
sistent with past studies (26, 27, 83), and further suggest that
while Yng1 can engage chromatin through both methyl-de-
pendent and -independent means, the interaction between
Pdp3 and chromatin requires H3K36me3.
Pdp3 is Required for NuA3-regulated Transcription—Muta-
tion of the Yng1 PHD finger results in genome-wide mislocal-
ization of NuA3 and decreased transcription of NuA3-regu-
lated loci (19). To further assess the function of Pdp3 in vivo,
we performed RT-qPCR with wild-type, pdp3	, and yng1	
cells, and calculated the relative transcript levels of NuA3-
regulated loci (Fig. 4A). As expected, yng1	 cells showed a
slight but significant decrease in the relative transcript levels
of NuA3 target genes, indicating a positive role for Yng1 in
NuA3 activity at these genes (Fig. 4A) (19, 84, 85). Interest-
ingly, pdp3	 cells also showed a reduced level of NuA3 target
gene transcript (Fig. 4A). These data indicate that NuA3 bind-
ing to both H3K4me3, via Yng1, and H3K36me3, via Pdp3, is
required for proper NuA3-directed transcription.
PDP3 and NuA3 have Genetic Links to SET2 and Promote
Transcription Elongation—Because Pdp3 binds H3K36me3
and is required for proper transcription in vivo, we predicted
that Pdp3 would show genetic interactions with genes in the
Set2/H3K36me pathway, and might influence transcription
elongation. One genetic assay that has been used to measure
the influence of Set2/H3K36 methylation on transcription
FIG. 3. Pdp3, but not Yng1, requires H3K36me3 for chromatin
association in vivo. A, TAP-tagged PDP3 yeast strains and B, TAP-
tagged YNG1 yeast strains were biochemically fractionated into chro-
matin-associated proteins and soluble proteins. Fractions were
probed for the presence of Pdp3 and Yng1, respectively. G6PDH and
H4 serve as both loading and fractionation controls.
FIG. 4. NuA3 function in transcription requires both Yng1 and
Pdp3. A, RT-qPCR analysis of WT, pdp3	, and yng1	 cells to deter-
mine the relative transcript levels of NuA3-target genes and nontarget
genes (SSA1 and SSB1). Transcript levels were normalized to Actin
expression. Error bars represent the S.E. of a representative experi-
ment (n  4) performed in triplicate. Asterisks indicate statistical
significance as determined by an unpaired two-tailed t test. *  p 
.05, **  p  .01, ***  p  .001. B, 2 ODs of the indicated yeast
strains were 5-fold serially diluted on SC-Ura (left) or SC-Ura  5-FOA
(right) plates and grown at 30 °C for 2 or 3 days, respectively. C, 0.5
ODs of the indicated yeast strains were 5-fold serially diluted onto
SC-Ura (left) or SC-Ura  150 g/ml 6-AU (right) plates and grown at
30 °C for 2 days.
A PWWP Protein Targets the NuA3 HAT Complex to Gene Bodies
Molecular & Cellular Proteomics 13.11 2889
elongation is the BUR1 bypass assay. Bur1, a cyclin-depend-
ent kinase, acts as a positive regulator of transcription
through the phosphorylation of several components of elon-
gating RNAPII, including the CTD of RNAPII and the Spt5
C-terminal repeat domain (86–88). Under normal conditions,
deletion of BUR1 is lethal; however, deletion of SET2 or
RCO1, a unique member of Rpd3S, bypasses this lethality
(34, 44). To explore whether Pdp3 and/or Yng1 contribute to
transcription elongation, we examined deletions of SET2,
RCO1, PDP3, and YNG1 in the bur1	 background. Although
the bur1	set2	 and bur1	rco1	 strains bypass the lethality
of BUR1 deletion as expected, neither bur1	pdp3	 nor
bur1	yng1	 cells are viable (Fig. 4B). This suggests that
either the bypass phenotype is too weak to observe, or Pdp3
and Yng1 function as positive elongation factors, and thus
would not display a positive growth phenotype in this assay.
To distinguish between these two possibilities, we created
triple mutant strains with PDP3 or YNG1 deleted in the
bur1	rco1	 background. Because this background shows a
bypass phenotype, we could now observe positive or nega-
tive growth changes resulting from the absence of Pdp3 or
Yng1. Significantly, the triple mutant strains both show a
decrease in growth as compared with the bur1	rco1	 back-
ground (Fig. 4B). These data suggest that Pdp3 and Yng1
positively regulate transcription elongation, and are consis-
tent with the idea that NuA3 functions both at promoters and
at gene bodies.
To further connect NuA3 activity to the transcription elon-
gation pathway, we asked whether the absence of NuA3
complex members resulted in sensitivity or resistance to the
transcription elongation inhibitor 6-azauracil (6-AU). Strains
containing a deletion of SET2, or downstream effectors, show
a 6-AU resistance phenotype (34, 44). As expected, strains
lacking Set2, Rco1, and Eaf3, a member of the Rpd3S HDAC
and NuA4 HAT complexes, display resistance to 6-AU as
compared with wild-type (Fig. 4C). Of all tested NuA3 mem-
bers, only pdp3	 cells show resistance to 6-AU, a result
consistent with the idea that Pdp3 functions in the Set2/
H3K36 methylation pathway (Fig. 4C).
PDP3 is not Synthetically Lethal with GCN5—It has previ-
ously been determined that NuA3 complex members, Sas3
and Yng1, display synthetic lethality with the HAT, Gcn5 (89).
These data indicate Gcn5 and Sas3 likely collaborate to pro-
mote gene activation and/or transcription elongation, as Gcn5
is found in both the promoters and transcribed regions of
genes (90, 91). Given the physical interaction and functional
overlap between NuA3 and Pdp3, we wanted to determine if
Pdp3 is also synthetically lethal with Gcn5. We created GCN5
shuffle strains that allowed us to delete YNG1 or PDP3 in a
gcn5	 background. Upon shuffling out the wild-type GCN5
plasmid, only gcn5	yng1	 cells display synthetic lethality
(supplemental Fig. S3). Surprisingly, gcn5	pdp3	 cells show
no deleterious phenotype (supplemental Fig. S3), indicating
PDP3 does not genetically interact with GCN5. These results
suggest that Pdp3-containg NuA3 participates in an alternate
transcriptional pathway that is distinct from the role of Gcn5 at
promoters and in gene bodies.
DISCUSSION
In this study, we characterize a unique form of the NuA3
HAT complex that contains the PWWP domain protein, Pdp3.
Using mass spectrometric, biochemical, and genetic ap-
proaches, our collective findings suggest that NuA3 exists in
two functionally distinct forms: NuA3a and NuA3b (Fig. 5).
This nomenclature has previously been used to distinguish
different variations of related protein complexes. For example,
although the Isw1a and Isw1b ATP-dependent chromatin re-
modeling complexes both have the same catalytic protein,
Isw1, Isw1b contains a unique PWWP domain protein, Ioc4,
required for targeting remodeling activity to H3K36me3 en-
riched nucleosomes (51, 52). For NuA3 complexes, we hy-
pothesize that promoter-associated NuA3a contains the pro-
teins Eaf6, Nto1, Sas3, Taf14, and Yng1, and specifically
associates with H3K4me3 using the PHD finger of Yng1 (Fig.
5A) (19, 24–27). NuA3a subsequently acetylates H3K14
through the HAT domain of Sas3, initiating transcription at a
subset of genes (Fig. 5A) (19, 24, 25). In contrast, NuA3b, via
the H3K36me3-binding PWWP domain protein Pdp3, links to
H3K36 methylation-associated transcription elongation in
gene bodies (Fig. 5B). Accordingly, our previous mass spec-
trometry (i-DIRT) data support the model that NuA3b is com-
positionally distinct from NuA3a (19). However, we cannot
exclude the alternate possibility that Pdp3 is a member of
both NuA3a and NuA3b. To this end, human H3K36me3-
binding BRPF proteins resemble a fusion of yeast Nto1 and
Pdp3, as if these separate NuA3 proteins are physically
linked within the human MOZ/MORF complexes (92). This
brings up the intriguing possibility that the PWWP domain of
Pdp3 (and potentially BRPFs) has a regulated capacity to
bind H3K36me3, becoming active or inactive in a context
dependent manner.
Our data clearly place Pdp3 and NuA3b within the Set2-de-
pendent transcriptional elongation pathway. Pdp3 binds to
H3K36me3, a Set2-catalyzed histone PTM found almost ex-
clusively within transcriptionally active gene bodies (13, 33–
35, 37, 40); and deletion of the PDP3 gene results in growth
defects when combined with transcription elongation mu-
tants. The interaction between Pdp3 and Rpb4, as deter-
mined from our mass spectrometry studies, further supports a
role for NuA3b in transcriptional elongation, given the links
between Rpb4 and actively transcribing RNAPII in S. pombe
(93). Although our data suggest that NuA3b positively regu-
lates transcription elongation, the exact function of NuA3b
remains unclear. Because NuA3-directed transcription is de-
creased in pdp3	 cells, NuA3b could participate in acetyla-
tion-dependent nucleosome eviction within the ORF, similar
to the proposed function of Gcn5 at coding regions (90, 94,
95). Although both Gcn5 and Sas3 favor acetylation of H3K14
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(19, 24, 25, 96–99), unlike NuA3a, NuA3b is not synthetically
lethal with deletion of GCN5, suggesting Sas3, within the
context of NuA3b, has a distinct function from Gcn5 (perhaps
acetylating other factors in the transcription elongation com-
plex or an alternate lysine(s) in histones) (Fig. 5B). This result,
and the finding that HBO1 (a related human MYST family HAT)
can switch between H4 and H3 acetylation depending on its
association with JADE1/2/3 or BRPF1, supports the idea that
NuA3b may target non-H3K14 substrates (100). It is also
possible that Gcn5-mediated H3 acetylation has a distinct
function from NuA3b acetylation at H3K14 in ORFs. Future
work is needed to determine the precise mechanism of
NuA3b function in the transcription elongation process.
A recurring question in chromatin biology is how the
addition or removal of methylation groups on specific lysine
residues can alter functional properties of the associated
chromatin. In yeast, Set2 catalyzes all three forms of H3K36
methylation (33). To date, H3K36me1 is suggested to func-
tion in DNA replication (101), and although H3K36me2 and
me3 are both linked to transcriptional elongation, H3K36me2
is essential for Rpd3S recruitment (18, 41–47), whereas
H3K36me3 is implicated in nucleosomal positioning via Isw1b
and repression of trans-histone exchange (50–52). Interestingly,
unlike H3K36me2, the establishment of H3K36me3 specifically
requires Set2 association with the CTD of RNAPII, and
H3K36me3 is positively correlated with the rate of transcription
(13). Consistent with H3K36me3 links to highly transcribed
genes, we speculate that H3K36me3, via association with
NuA3b, may have an alternate function on NuA3-regulated
genes that is distinct from former pathways determined for
H3K36 methylation. The finding that the HDAC Rpd3S is linked
to H3K36me2, whereas the HAT complex NuA3b is linked to
CTD-dependent H3K36me3, suggests that differential methyl-
ation of H3K36 may act as a “chromatin switch” to regulate
overall levels of transcription. For example, on lowly transcribed
genes, the H3K36me2 state may predominate and recruit
Rpd3S to maintain a more repressed chromatin environment
suitable for low-level transcription. Conversely, on highly tran-
scribed genes, H3K36me3 may predominate and recruit NuA3b
to facilitate nucleosome disruption for RNAPII elongation (on
genes regulated by NuA3). Alternatively, both H3K36me2 and
me3 may be coordinating HDAC and HAT activities together,
within the same coding region, to properly modulate the pro-
gression of RNAPII during transcriptional elongation. Although
speculative, these intriguing models await testing.
Finally, NuA3 joins a growing list of HAT complexes that can
localize to both promoters and gene bodies by modulating
complex components (90, 94, 102–104). Whether NuA3b en-
gages a dual H3K4me/H3K36me signature, through the com-
binatorial action of the PHD finger of Yng1 and the PWWP
FIG. 5. The NuA3 HAT complex has two functionally distinct forms that participate in transcription. A, Model of the NuA3a HAT
complex. Yng1 binds to H3K4me3 through its PHD finger, thereby recruiting NuA3a to the promoter regions of actively transcribed genes. Sas3
then acetylates H3K14, leading to transcription initiation at a subset of genes (19, 24–27). B, Model of the NuA3b HAT complex. NuA3b
contains a unique member, Pdp3. Pdp3 binds to H3K36me3 through its PWWP domain, thereby recruiting NuA3b to the coding regions of
actively transcribed genes. Although the function of NuA3b is not fully defined, we speculate that Sas3 may acetylate histones or nonhistone
proteins to facilitate transcription elongation.
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domain of Pdp3, to fine-tune transcription initiation and elon-
gation pathways, remains an important question for future
studies. It is worth noting that mutations of NuA3 human
homologs (23, 56) are associated with oral squamous cell
carcinoma (105) and acute myeloid leukemia (106). Given that
HATs and many other chromatin-bound protein complexes
are gaining favor as pharmaceutical targets (107–110), future
studies into the PWWP domain of Pdp3 and NuA3b may
elucidate how chromatin effectors contribute to human dis-
ease, thereby opening up new targets for drug discovery.
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